Menu
  • 2020 Date Announced: The 4th Annual US E-Cigarette Summit will take place May 4 2020

 

2018 Speakers

Prof Thomas J. Glynn, PhD
Prof Thomas J. Glynn, PhD

Adjunct Lecturer, Stanford Prevention Research Centre, Stanford University School of Medicine

Thomas J. Glynn, PhD is currently Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine, in Palo Alto, California. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS), in Washington, DC. In these positions, he advised the ACS about emerging research and policy issues in tobacco/cancer prevention and control, recommended tobacco/cancer prevention and control research and policy which is ready for national/global application, and participated in the development of an international cancer control program aimed at promoting tobacco and cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.

Prior to coming to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute’s (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI’s Cancer Control Extramural Research Branch. There, he directed the development of a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI’s Smoking, Tobacco, and Cancer Program.

Dr. Glynn is widely published on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education audiences. He has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, Mayo Clinic, and state and local governments, as well as a wide range of international organizations. He has also served as a Senior Scientific Reviewer for many U.S. Surgeon General’s Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. His awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the American Society of Preventive Oncology Joseph W. Cullen Memorial Award, and the SRNT’s John Slade Award.

 

Dr Robin Mermelstein
Dr Robin Mermelstein

Professor of Psychology and IHRP Director, University of Illinois, Chicago

Robin Mermelstein, PhD. is Distinguished Professor, Psychology Department; Director of the Institute for Health Research and Policy at the University of Illinois at Chicago (UIC), and Co-Director of UIC’s Center for Clinical and Translational Science.  Dr. Mermelstein has been active in health-behavior research for 30 years, with continuous NIH funding as a Principal Investigator on grants since 1986. Dr. Mermelstein was acknowledged by the NCI as a Research Pioneer in the Division of Cancer Control and Population Sciences. She is nationally recognized for her expertise in understanding trajectories and developmental patterns of youth tobacco use, for employing novel approaches to studying contextual factors in the development of nicotine dependence and health risk behaviors, for developing innovative health behavior clinical interventions for adolescents and adults, and for methodological issues in conducting tobacco-related research. She has been the PI of several large-scale, multidisciplinary program project and center grants, as well as the Director of a national program or the Robert Wood Johnson Foundation. Dr. Mermelstein has served on many NIH advisory and review committees, including being a former standing member of the NCI-A Cancer Centers review committee; a former member of the External Scientific Advisory Panel for the NCI’s Science of Research and Technology Branch; co-Chair of the NCI’s Tobacco Control Priorities Consultant Group; a former standing member of the National Institute on Drug Abuse’s K-award study section; and a current member of the External Scientific Advisory Board for the Adolescent Brain and Cognitive Development Study (ABCD Study) of NIH. She has been acknowledged for her scientific accomplishments by several national and international research societies, including being named a Fellow of the Association of Psychological Science, a Fellow of the Society of Behavioral Medicine, and a Fellow of the Society for Research in Nicotine and Tobacco. She is a past President of the Society for Research on Nicotine and Tobacco (2015-2016).

 

Dr. Lion Shahab
Dr. Lion Shahab

Associate Professor in Health Psychology, University College London

Dr Shahab is a Senior Lecturer/Associate Professor in Health Psychology at University College London and trained in psychology, epidemiology and neuroscience. He has more than 12 years’ experience in addiction research, tobacco control and health psychology with a particular interest in novel behavioural and pharmacological smoking cessation interventions, biomarkers, tobacco product regulation and policy, digital health and tobacco and alcohol use epidemiology. Dr Shahab has collaborated with academic as well as non-academic (e.g. governmental and non-governmental) partners and to date has authored over 75 scientific papers, reports and reviews in this area.

Deborah Arnott
Deborah Arnott

Chief Executive, Action on Smoking and Health (UK)

Deborah Arnott is a recognised international expert on tobacco control and the WHO Framework Convention on Tobacco Control, with a particular interest in nicotine regulation and harm reduction. She was a member of the National Institute for Health and Care Excellence committee which developed guidance for England on tobacco harm reduction and of an expert advisory group to the UK’s medicines regulator the MHRA on e-cigarettes.  She also has experience of product regulation under the EU General Product Safety Directive having participated in the development of fire safety requirements for cigarettes.

Deborah has an MBA from Cranfield, is an honorary Associate Professor at the University of Nottingham, and a member of the Royal College of Physicians Tobacco Advisory Group.  She was awarded the Alwyn Smith prize in 2007 by the Faculty of Public Health for her outstanding contribution to public health.

Competing Interest: None Stated

Professor Ann McNeill
Professor Ann McNeill

Professor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies (UKCTAS), Kings College London

Ann McNeill is a Professor of Addictions in the National Addiction Centre with a focus on tobacco. She graduated from the University of Nottingham with a first class joint honours degree in zoology and psychology and then carried out her PhD at the Institute of Psychiatry focusing on the development of dependence on smoking. Since that time she has held a variety of academic and public sector posts focusing largely on tobacco control research. Ann has an established international reputation, receiving a World Health Organisation award for contributions to tobacco control in 1998.

She has published more than 250 academic papers book chapters, reports and opinion pieces on the subject and her research ranges across prevention, cessation, harm reduction and local, national and international policy. Ann was a co-author of the recent systematic review of tobacco product packaging which underpinned the recent government consultation on plain packaging and has a particular interest in the relationship between smoking, mental health and inequalities. She is Deputy Director of the UK Centre for Tobacco Control Studies.

Competing Interest: None Stated

Clive Bates
Clive Bates

Director, Counterfactual Consulting Ltd

Clive Bates has had a diverse career in the public, private and not-for-profit sectors.  He started out with the IT company, IBM, then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.

Matthew L. Myers
Matthew L. Myers

President, Campaign for Tobacco-Free Kids

Matthew L. Myers is President of the Campaign for Tobacco-Free Kids, a leader in the fight to reduce tobacco use and its devastating consequences in the United States and around the world.

In 1996, Mr. Myers helped to found the Campaign for Tobacco-Free Kids and has been with the Campaign since its inception. Initially, he served as its Executive Vice President and Legal Counsel and oversaw the Campaign’s legal and advocacy efforts. On January 1, 2000, Mr. Myers became the Campaign’s President.

In his position at the Campaign Mr. Myers helped to lead the Campaign’s effort to defend FDA’s assertion of jurisdiction over cigarettes and smokeless tobacco products in 1996.  Mr Myers then served as a close advisor to the State Attorneys General in the 1990s when they sued the tobacco industry.

He participated in the 1996 negotiations that led to the first ever settlement with a tobacco company, Liggett and Myers, an agreement that broke the tobacco industry’s unity and resulted in the release of a massive amount of previously secret tobacco industry documents.

In 1997, at the request of the State Attorneys General and the White House, Mr. Myers participated in the negotiations that led to the unprecedented agreement between the tobacco industry and the states in June 1997. He then served as one of the leading spokespersons for the legislative debate related to that settlement that followed in Congress.

Mr. Myers subsequently advised a number of State Attorneys General during the negotiations that led to the Master Settlement Agreement in 1998 and oversaw the Campaign’s effort to get the states to use Master Settlement Agreement funds for comprehensive tobacco control.

Since that time under Mr. Myers’ leadership the Campaign has been a leader in the effort to raise tobacco taxes, expand protection against secondhand smoke and fund effective comprehensive tobacco control programs at the state level